(Q34664004)

3 August 2017

title

Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial (English)

1 reference

3 August 2017

1 reference

Judith Currier

1

1 reference

3 August 2017

Dawn Averitt Bridge

2

1 reference

3 August 2017

Debbie Hagins

3

1 reference

3 August 2017

Carmen D Zorrilla

4

1 reference

3 August 2017

Judith Feinberg

5

1 reference

3 August 2017

Robert Ryan

6

1 reference

3 August 2017

Ron Falcon

7

1 reference

3 August 2017

Alan Tennenberg

8

1 reference

3 August 2017

Joseph Mrus

9

1 reference

3 August 2017

Kathleen Squires

10

1 reference

3 August 2017

GRACE (Gender, Race, And Clinical Experience) Study Group

11

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 September 2010

1 reference

Annals of Internal Medicine

3 August 2017

published in

1 reference

3 August 2017

volume

153

1 reference

3 August 2017

issue

6

1 reference

3 August 2017

page(s)

349-357

1 reference

Representation of women in randomized clinical trials of cardiovascular disease prevention

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

Gender differences in discontinuation of antiretroviral treatment regimens.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

Gender differences in predictors of treatment attrition with high dose naltrexone in cocaine and alcohol dependence

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

Sex differences in pharmacokinetics and toxicity of antiretroviral therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

Sex differences in antiretroviral therapy-associated intolerance and adverse events

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

Gender bias in clinical trials: do double standards still apply?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

Under-representation of women in high-impact published clinical cancer research.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

A once-daily lopinavir/ritonavir-based regimen is noninferior to twice-daily dosing and results in similar safety and tolerability in antiretroviral-naive subjects through 48 weeks

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

HIV prevalence estimates--United States, 2006.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

Gender differences in the diagnosis and treatment of HIV.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

Safety and efficacy of darunavir (TMC114) with low-dose ritonavir in treatment-experienced patients: 24-week results of POWER 3.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056066

Participation in cancer clinical trials: race-, sex-, and age-based disparities

26 October 2018

1 reference

12 December 2020

Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute

1 reference

12 December 2020

HIV infection in women: do sex and gender matter?

1 reference

12 December 2020

Investigational new drug applications and new drug applications--FDA. Final rule

1 reference

12 December 2020

10.7326/0003-4819-153-6-201009210-00002

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference